Article info

Original research
Time to treatment with bridging intravenous alteplase before endovascular treatment:subanalysis of the randomized controlled SWIFT-DIRECT trial

Authors

  1. Correspondence to Dr Urs Fischer, Department of Neurology, Inselspital Universitatsspital Bern, Bern, Bern, Switzerland; urs.fischer{at}usb.ch
View Full Text

Citation

Meinel TR, Kaesmacher J, Buetikofer L on behalf of the SWIFT-DIRECT investigators, et al
Time to treatment with bridging intravenous alteplase before endovascular treatment:subanalysis of the randomized controlled SWIFT-DIRECT trial

Publication history

  • Received June 1, 2022
  • Accepted July 13, 2022
  • First published July 28, 2022.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.